Factors Affecting Testosterone and How to Maintain Balance – Testosterone is a vital hormone that regulates energy, strength, muscle mass, bone density, and sexual health. While levels naturally change throughout life, many lifestyle and environmental influences can either reduce or support healthy testosterone production. Below are seven major factors that affect testosterone and practical ways to maintain balance.
Diet and Nutrition for Hormonal Health
Hormones are chemical messengers that regulate nearly every function in the body—from metabolism and mood to reproductive health, sleep, and energy balance. When they fall out of balance, symptoms such as fatigue, mood swings, irregular cycles, weight fluctuations, and even skin issues can appear. While genetics and lifestyle play roles, diet and nutrition are among the most powerful tools we have to support healthy hormone function. The right foods can help stabilize blood sugar, reduce inflammation, support detoxification, and provide the building blocks the body needs for optimal hormonal balance.
Normal Testosterone Levels by Age and Gender
Testosterone is a vital hormone that supports physical health, sexual development, energy, and overall well-being. While most people associate testosterone primarily with men,
Lifestyle Changes to Naturally Boost Testosterone
Testosterone is one of the most important hormones for overall health, influencing everything from muscle mass and bone strength to mood, energy, and sexual function.
Testosterone is a hormone that plays a central role in human health, particularly in men but also in women. It belongs to a group of hormones known as androgens and is primarily produced in the testes in men and the ovaries in women, with small amounts also secreted by the adrenal glands. Though testosterone is often associated with masculinity, its influence extends far beyond sexual traits—it impacts physical health, mental well-being, and overall quality of life.
Suzetrigine, marketed as Journavx, is a first-in-class, oral, non-opioid analgesic, officially approved by the FDA on January 30, 2025 for treating moderate-to-severe acute pain in adults. It fills a long-standing void—being the first new non-opioid pain medication approved in over 20 years.
Avmapki Fakzynja Co-Pack, a co-packaged oral combination of avutometinib capsules and defactinib tablets, received accelerated approval from the U.S. FDA on May 8, 2025 for the treatment of adult patients with KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC) who have undergone at least one prior systemic therapy
FDA – U.S. Food and Drug Administration (FDA) approved Belzutifan (brand name Welireg, developed by Merck & Co.) for the treatment of locally advanced, unresectable, or metastatic pheochromocytoma and paraganglioma (PPGL)
From January to August 2025, the FDA approved 25 novel drugs – nearly one per week – reflecting an unprecedented pace in expanding treatment options across therapeutic areas
Dr. Vinay Prasad, a hematologist-oncologist and outspoken critic of both FDA approval standards and public health policy, was appointed in May 2025 by Commissioner Marty Makary to lead CBER, the FDA division overseeing vaccines, gene therapies, and blood products
